The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3393356)

Published in J Radiat Res on June 05, 2012

Authors

Yao-Ching Wang1, Te-Chun Hsieh, Chun-Yen Yu, Kuo-Yang Yen, Shang-Wen Chen, Shih-Neng Yang, Chun-Ru Chien, Shih-Ming Hsu, Tinsu Pan, Chia-Hung Kao, Ji-An Liang

Author Affiliations

1: Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.

Articles cited by this

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol (2007) 6.82

18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med (2006) 3.20

Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol (2008) 2.07

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol (2004) 1.92

Evidence-based radiation oncology: oesophagus. Radiother Oncol (2009) 1.55

Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys (2007) 1.43

Design of 4D treatment planning target volumes. Int J Radiat Oncol Biol Phys (2006) 1.43

PET-based treatment planning in radiotherapy: a new standard? J Nucl Med (2007) 1.42

4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. Radiother Oncol (2009) 1.39

The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.30

Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study. Int J Radiat Oncol Biol Phys (2009) 1.17

Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys (2008) 1.16

PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings? Int J Radiat Oncol Biol Phys (2009) 1.11

(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT. Int J Radiat Oncol Biol Phys (2009) 1.09

Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer. Int J Radiat Oncol Biol Phys (2010) 1.08

Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys (2009) 1.03

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.03

Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques. Radiother Oncol (2010) 1.01

The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions. Ann Nucl Med (2009) 1.01

(18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications. Ann Nucl Med (2010) 1.00

A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol (2010) 1.00

Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. Radiother Oncol (2009) 0.96

Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.95

Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2007) 0.95

Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin Radiol (2009) 0.93

Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med (2007) 0.90

Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys (2008) 0.86

Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation. Int J Radiat Oncol Biol Phys (2008) 0.85

GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer. Radiother Oncol (2009) 0.82

Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Clin Oncol (R Coll Radiol) (2008) 0.79

Articles by these authors

Four-dimensional computed tomography: image formation and clinical protocol. Med Phys (2005) 2.78

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys (2007) 2.35

Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. J Clin Psychiatry (2012) 2.29

Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med (2007) 2.29

Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J (2013) 2.18

Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13

Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys (2007) 1.89

Four-dimensional cone beam CT with adaptive gantry rotation and adaptive data sampling. Med Phys (2007) 1.84

Dynamic ventilation imaging from four-dimensional computed tomography. Phys Med Biol (2006) 1.80

Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys (2007) 1.74

A motion-incorporated reconstruction method for gated PET studies. Phys Med Biol (2006) 1.69

Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation. Int J Radiat Oncol Biol Phys (2010) 1.64

Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2012) 1.61

Attention-deficit-hyperactivity disorder increases risk of bone fracture: a population-based cohort study. Dev Med Child Neurol (2014) 1.58

Cancer risk in patients with Graves' disease: a nationwide cohort study. Thyroid (2013) 1.50

Low-dose CT reconstruction via edge-preserving total variation regularization. Phys Med Biol (2011) 1.50

Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study. J Periodontol (2013) 1.50

Non-apnea sleep disorder increases the risk of periodontal disease: a retrospective population-based cohort study. J Periodontol (2013) 1.48

Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J (2008) 1.47

Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.47

The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med (2004) 1.44

Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response. Clin Cancer Res (2008) 1.33

Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. Int J Radiat Oncol Biol Phys (2007) 1.27

Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin Proc (2012) 1.26

Abnormal FDG PET imaging in tuberculosis appearing like lymphoma. Clin Nucl Med (2004) 1.22

Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res (2003) 1.18

Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging (2012) 1.17

Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol (2006) 1.10

Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck (2009) 1.09

The association between malignancy and end-stage renal disease in Taiwan. Jpn J Clin Oncol (2011) 1.09

4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol (2008) 1.08

Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer. Med Dosim (2005) 1.08

5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One (2012) 1.07

A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis. J Altern Complement Med (2008) 1.06

18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer (2003) 1.06

New vertebral osteoporotic compression fractures after percutaneous vertebroplasty: retrospective analysis of risk factors. J Vasc Interv Radiol (2008) 1.05

FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis. Clin Nucl Med (2012) 1.04

Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res (2005) 1.04

Region of interest motion compensation for PET image reconstruction. Phys Med Biol (2007) 1.03

Quantitative assessment of four-dimensional computed tomography image acquisition quality. J Appl Clin Med Phys (2007) 1.03

Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis. Int J Colorectal Dis (2013) 1.02

Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol (2013) 1.02

Inflammatory myofibroblastic tumor mimicking adrenal incidentaloma. Intern Med (2011) 1.02

The analysis of depression and subsequent cancer risk in Taiwan. Cancer Epidemiol Biomarkers Prev (2011) 1.01

Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys (2006) 1.01

18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Radiol (2011) 1.00

Relation of external surface to internal tumor motion studied with cine CT. Med Phys (2006) 0.98

Four-dimensional dosimetry validation and study in lung radiotherapy using deformable image registration and Monte Carlo techniques. Radiat Oncol (2010) 0.97

Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy. Eur J Nucl Med Mol Imaging (2012) 0.97

Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res (2006) 0.97

Autoadaptive phase-correlated (AAPC) reconstruction for 4D CBCT. Med Phys (2009) 0.97

Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in non-small cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol (2012) 0.96

Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis. Eur J Radiol (2011) 0.96

Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One (2011) 0.95

Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer. Anticancer Res (2012) 0.95

Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging (2006) 0.95

Design of respiration averaged CT for attenuation correction of the PET data from PET/CT. Med Phys (2007) 0.95

Increased risks of deep vein thrombosis and pulmonary embolism in Sjögren syndrome: a nationwide cohort study. J Rheumatol (2014) 0.95

Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study. Inflamm Bowel Dis (2016) 0.94

Application of PET and PEt/CT imaging for cancer screening. Anticancer Res (2005) 0.94

Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep (2010) 0.94

Implementation of an automated respiratory amplitude gating technique for PET/CT: clinical evaluation. J Nucl Med (2009) 0.94

Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.93

Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Gynecol Oncol (2004) 0.93

Detection of gastroesophageal reflux esophagitis using 2-fluoro-2-deoxy-d-glucose positron emission tomography. ScientificWorldJournal (2012) 0.92

Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening. Eur J Radiol (2011) 0.92

Potential value of dual-time-point ¹⁸F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis. Nucl Med Commun (2012) 0.92

A Nationwide Population-Based Cohort Study of Migraine and Organic-Psychogenic Erectile Dysfunction. Medicine (Baltimore) (2016) 0.91

Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med (2003) 0.91

Extracting respiratory signals from thoracic cone beam CT projections. Phys Med Biol (2013) 0.91

Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2004) 0.91

A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia. Clin Endocrinol (Oxf) (2014) 0.91

3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world. Lung Cancer (2012) 0.91

The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol (2014) 0.91

Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease. Nucl Med Commun (2004) 0.91

A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study. PLoS One (2012) 0.91

The effect of yoga exercise on improving depression, anxiety, and fatigue in women with breast cancer: a randomized controlled trial. J Nurs Res (2014) 0.90